Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. FUT2-ABO epistasis increases the risk of early childhood asthma and Streptococcus pneumoniae respiratory illnesses

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Interethnic analyses of blood pressure loci in populations of East Asian and European descent

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Triglycerides as a shared risk factor between dementia and atherosclerotic cardiovascular disease: a study of 125 727 individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Associations between body mass index trajectories in childhood and cardiovascular risk factors in adulthood

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Occupational exposures and exacerbations of asthma and COPD-A general population study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Viktoria Gusarova
  • Colm O'Dushlaine
  • Tanya M. Teslovich
  • Peter N. Benotti
  • Tooraj Mirshahi
  • Omri Gottesman
  • Cristopher V. Van Hout
  • Michael F. Murray
  • Anubha Mahajan
  • Jonas B. Nielsen
  • Lars Fritsche
  • Anders Berg Wulff
  • Daniel F. Gudbjartsson
  • Marketa Sjögren
  • Connor A. Emdin
  • Robert A. Scott
  • Wen Jane Lee
  • Aeron Small
  • Lydia C. Kwee
  • Om Prakash Dwivedi
  • Rashmi B. Prasad
  • Shannon Bruse
  • Alexander E. Lopez
  • John Penn
  • Anthony Marcketta
  • Joseph B. Leader
  • Christopher D. Still
  • H. Lester Kirchner
  • Uyenlinh L. Mirshahi
  • Amr H. Wardeh
  • Cassandra M. Hartle
  • Lukas Habegger
  • Samantha N. Fetterolf
  • Teresa Tusie-Luna
  • Andrew P. Morris
  • Hilma Holm
  • Valgerdur Steinthorsdottir
  • Patrick Sulem
  • Unnur Thorsteinsdottir
  • Jerome I. Rotter
  • Lee Ming Chuang
  • Scott Damrauer
  • David Birtwell
  • Chad M. Brummett
  • Amit V. Khera
  • Pradeep Natarajan
  • Marju Orho-Melander
  • Jason Flannick
  • Luca A. Lotta
  • Cristen J. Willer
  • Oddgeir L. Holmen
  • Marylyn D. Ritchie
  • David H. Ledbetter
  • Andrew J. Murphy
  • Ingrid B. Borecki
  • Jeffrey G. Reid
  • John D. Overton
  • Ola Hansson
  • Leif Groop
  • Svati H. Shah
  • William E. Kraus
  • Daniel J. Rader
  • Yii Der I. Chen
  • Kristian Hveem
  • Nicholas J. Wareham
  • Sekar Kathiresan
  • Olle Melander
  • Kari Stefansson
  • Børge G. Nordestgaard
  • Anne Tybjærg-Hansen
  • Goncalo R. Abecasis
  • David Altshuler
  • Jose C. Florez
  • Michael Boehnke
  • Mark I. McCarthy
  • George D. Yancopoulos
  • David J. Carey
  • Alan R. Shuldiner
  • Aris Baras
  • Frederick E. Dewey
  • Jesper Gromada
View graph of relations

Angiopoietin-like 4 (ANGPTL4) is an endogenous inhibitor of lipoprotein lipase that modulates lipid levels, coronary atherosclerosis risk, and nutrient partitioning. We hypothesize that loss of ANGPTL4 function might improve glucose homeostasis and decrease risk of type 2 diabetes (T2D). We investigate protein-altering variants in ANGPTL4 among 58,124 participants in the DiscovEHR human genetics study, with follow-up studies in 82,766 T2D cases and 498,761 controls. Carriers of p.E40K, a variant that abolishes ANGPTL4 ability to inhibit lipoprotein lipase, have lower odds of T2D (odds ratio 0.89, 95% confidence interval 0.85-0.92, p = 6.3 × 10-10), lower fasting glucose, and greater insulin sensitivity. Predicted loss-of-function variants are associated with lower odds of T2D among 32,015 cases and 84,006 controls (odds ratio 0.71, 95% confidence interval 0.49-0.99, p = 0.041). Functional studies in Angptl4-deficient mice confirm improved insulin sensitivity and glucose homeostasis. In conclusion, genetic inactivation of ANGPTL4 is associated with improved glucose homeostasis and reduced risk of T2D.

Original languageEnglish
Article number2252
JournalNature Communications
Volume9
Issue number1
Pages (from-to)2252
ISSN2041-1723
DOIs
Publication statusPublished - 1 Dec 2018

ID: 55678524